| Authors: |
Samol J; Medical Oncology Department Tan Tock Seng Hospital, Singapore; Johns Hopkins University, USA; Lee Kong Chian, School of Medicine, SG, Singapore. Electronic address: Jens_SAMOL@ttsh.com.sg., Demedts I; Department of Pulmonary Diseases, AZ Delta, Roeselare, Belgium., Erman M; Hacettepe University Cancer Institute, Ankara, Türkiye., Kozlov V; Novosibirsk Regional Clinical Oncology Dispensary, Moscow, Russia., Minatta JN; Hospital Universitario Austral, Buenos Aires, Argentina., Moiseenko F; Saint Petersburg Scientifical Practical Center of Specialized Kinds of Medical Care (Oncological), St. Academic University, Saint Petersburg, Russia., Mark M; Division of Oncology/Hematology, Kantonsspital Graubuenden, Chur, Switzerland; Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland., Rajappa S; Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India., Bailey T; Adelphi Real World, Bollington, UK., Wallis H; Adelphi Real World, Bollington, UK., Servidio L; Head of TDR, AstraZeneca, Gaithersburg, USA., Kahangire DA; Global Medical Affairs Oncology, AstraZeneca, Cambridge, UK., Zukin M; Oncologia D'Or Rio de Janeiro, Rede D'Or, Rio de Janeiro, Brazil; Instituto D'Or de Pesquisa e Ensino (ID'Or), Rio de Janeiro, Brazil. |